Drug Design, Development and Therapy is an Open Access peer-reviewed journal covering the spectrum of drug design, discovery, and development through to clinical applications.
The journal’s audience includes pharmaceutical chemist, Clinicians, Principal investigators with academic and industry profiles interested in specific topics which include:
- Drug target identification and validation
- Phenotypic screening and target deconvolution
- Biochemical analyses of drug targets and their pathways
- New methods or relevant applications in molecular/drug design and computer-aided drug discovery*
- Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)
- Structural or molecular biological studies elucidating molecular recognition processes
- Fragment-based drug discovery
- Pharmaceutical/red biotechnology
- Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**
- Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development
- Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)
- Preclinical development studies
- Translational animal models
- Mechanisms of action and signalling pathways
- Toxicology
- Gene therapy, cell therapy and immunotherapy
- Personalized medicine and pharmacogenomics
- Clinical drug evaluation
- Patient safety and sustained use of medicines
The journal provides an open access platform to outstanding reviews on drug efficacy, therapies, and drug profiles. We are proud our authors show high level of satisfaction based on engaged Editor in Chief and Editorial Board, a quality peer review, and a rapid decision making.
The journal welcomes for consideration the following paper types: original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. All articles received by the Journal will be subject to a single-anonymous peer review.
The journal does not accept study protocols or case reports.
*Computational modelling, in silico screening and molecular docking studies must be validated using appropriate in vitro or in vivo methods.
**Plant extract studies will only be considered if the active compound has been identified and validated.
When considering submission of a paper utilizing publicly available data authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample.
All authors who want to submit their work to Drug Design, Development and Therapy must adhere to the guidelines provided in the Editorial titled ‘ Statistical Analysis in Clinical and Experimental Medical Research: Simplified Guidance for Authors and Reviewers’. The Editorial can be found here.
Read the Instructions for Authors for information on how to submit your article.
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})